tenk.fyi

4D Molecular Therapeutics, Inc.

FDMTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$37,000

99.8% YoY

Net Income

-$160.9M

59.5% YoY

EPS

$-2.98

15.5% YoY

Cash

$149.3M

40.1% YoY

FY 2024 · As of 2024-12-31